Uncategorized

SOLVED

Question
Answered
Asked by ChancellorHeatRedPanda27
. A 52 y/o female with history of chronic middle insomnia is inquiring about switching to extended release formulation of Trazodone so that she will be able to sleep better. She is currently prescribed 50 mg nightly and denies any presence of substance use disorder or side effects on trazodone. Patient education in this scenario should include which of the following relevant information? a. Trazodone, in lower doses and in immediate release formulations, is most effective in attenuating depressive symptoms and less effective in treating early insomnia b. Trazodone, in higher doses and in extended release formulations, is more effective in treating depression, but extended release can induce hypersedation during the daytime c. Trazodone, in higher doses and in immediate release formulations, is not effective in treating difficulty with sleep onset d. Trazodone, in higher doses and in extended release formulations, is more effective in treating depressive symptoms, but extended release can cause hypersomnolence during the nighttime
SCIENCE
HEALTH SCIENCE
NURSING

 
******CLICK ORDER NOW BELOW TO GET THE ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION*******."

Leave a Reply

Your email address will not be published. Required fields are marked *